Meritage Portfolio Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.91M | Sell |
31,815
-149
| -0.5% | -$27.7K | 0.37% | 71 |
|
|
2025
Q1 | $6.7M | Sell |
31,964
-1,035
| -3% | -$217K | 0.44% | 63 |
|
|
2024
Q4 | $5.86M | Sell |
32,999
-536
| -2% | -$95.2K | 0.36% | 69 |
|
|
2024
Q3 | $6.62M | Sell |
33,535
-598
| -2% | -$118K | 0.41% | 68 |
|
|
2024
Q2 | $5.85M | Buy |
34,133
+1,119
| +3% | +$192K | 0.37% | 80 |
|
|
2024
Q1 | $6.01M | Buy |
33,014
+28,456
| +624% | +$5.18M | 0.38% | 79 |
|
|
2023
Q4 | $706K | Buy |
4,558
+888
| +24% | +$138K | 0.05% | 219 |
|
|
2023
Q3 | $547K | Sell |
3,670
-76
| -2% | -$11.3K | 0.04% | 231 |
|
|
2023
Q2 | $505K | Sell |
3,746
-133
| -3% | -$17.9K | 0.04% | 243 |
|
|
2023
Q1 | $618K | Sell |
3,879
-19,157
| -83% | -$3.05M | 0.05% | 197 |
|
|
2022
Q4 | $3.72M | Buy |
23,036
+1,191
| +5% | +$192K | 0.29% | 120 |
|
|
2022
Q3 | $2.93M | Buy |
21,845
+1,038
| +5% | +$139K | 0.24% | 123 |
|
|
2022
Q2 | $3.19M | Sell |
20,807
-10,906
| -34% | -$1.67M | 0.25% | 126 |
|
|
2022
Q1 | $5.14M | Buy |
31,713
+433
| +1% | +$70.2K | 0.32% | 97 |
|
|
2021
Q4 | $4.24M | Sell |
31,280
-2,629
| -8% | -$356K | 0.24% | 113 |
|
|
2021
Q3 | $3.66M | Sell |
33,909
-422
| -1% | -$45.5K | 0.22% | 122 |
|
|
2021
Q2 | $3.87M | Buy |
34,331
+114
| +0.3% | +$12.8K | 0.23% | 129 |
|
|
2021
Q1 | $3.7M | Sell |
34,217
-2,130
| -6% | -$231K | 0.25% | 123 |
|
|
2020
Q4 | $3.9M | Buy |
36,347
+9,801
| +37% | +$1.05M | 0.29% | 80 |
|
|
2020
Q3 | $2.33M | Buy |
+26,546
| New | +$2.33M | 0.21% | 130 |
|